Inquirer on MSN6d
World’s first anti-depression nasal spray receives FDA approval
The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
Badger Herald5d
Ketamine’s path to Medicaid coverage in Wisconsin marked by optimism, gathering acceptance
Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...
Channel NewsAsia Singapore5d
Janil Puthucheary on use of ketamine to treat severe depression
The use of ketamine to treat severe depression was approved in Singapore in October 2020, to be administered as a nasal spray together with oral anti-depressant therapy. Clinical trials have shown ...
pharmaphorum3d
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...
Science News9h
A man volunteered to get brain implants for depression. Hear his story
In the first episode of The Deep End Podcast, we meet Jon Nelson, who shares why he volunteered to get brain implants for his relentless depression.
Psychology Today6d
Ketamine-Assisted Psychiatrists in Beverly, MA
Find Ketamine-Assisted Psychiatrists in Beverly, Essex County, Massachusetts, get help from a Beverly Ketamine-Assisted Psychiatrist in Beverly. Menu Psychology Today Psychiatrists ...
Mothership.sg5d
Stringent safeguards in place to prevent abuse of ketamine spray used to treat depression
Ketamine, when abused, can be tremendously harmful and addictive. Nevertheless, esketamine, a dissociative hallucinogen that is administered by nasal spray, can be beneficial within a clinical ...
pharmaphorum2d
J&J builds case for antidepressant Spravato with head-to-head trial
"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat ... an intranasal formulation of racemic ketamine. Bain Capital has agreed to buy Mitsubishi ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Hosted on MSN2h
Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application ...
Medscape5d
Warning of Confusion Between Nasal and IV Epinephrine
Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to ...